747
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Predictors for cannabis cessation during pregnancy: a 10-year cohort study

ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Article: 2319290 | Received 13 Dec 2023, Accepted 11 Feb 2024, Published online: 24 Feb 2024

References

  • Brown QL, Sarvet AL, Shmulewitz D, et al. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA. 2017;317(2):1–8. doi:10.1001/jama.2016.17383
  • Young-Wolff KC, Tucker LY, Alexeeff S, et al. Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009–2016. JAMA. 2017;318(24):2490–2491. doi:10.1001/jama.2017.17225
  • Saurel‐Cubizolles M, Prunet C, Blondel B. Cannabis use during pregnancy in France in 2010. BJOG. 2014;121(8):971–977. doi:10.1111/1471-0528.12626
  • Jarlenski M, Zank J, Tarr J, et al. Public health messages about perinatal marijuana use in an evolving policy context. Subst Abus. 2017;38(1):48–54. doi:10.1080/08897077.2016.1268240
  • Corsi DJ, Hsu H, Weiss D, et al. Trends and correlates of cannabis use in pregnancy: a population-based study in Ontario, Canada from 2012 to 2017. Can J Public Health. 2019;110(1):76–84. doi:10.17269/s41997-018-0148-0
  • Crume TL, Juhl AL, Brooks-Russell A, et al. Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pediatr. 2018;197:90–96. doi:10.1016/j.jpeds.2018.02.005
  • Bandoli G, Jelliffe-Pawlowski L, Schumacher B, et al. Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend. 2021;225:108757. doi:10.1016/j.drugalcdep.2021.108757
  • Mark K, Gryczynski J, Axenfeld E, et al. Pregnant women’s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm. J Addict Med. 2017;11(3):211–216. doi:10.1097/ADM.0000000000000299
  • Passey ME, Sanson-Fisher RW, D’Este CA, et al. Tobacco, alcohol and cannabis use during pregnancy: clustering of risks. Drug Alcohol Depend. 2014;134:44–50. doi:10.1016/j.drugalcdep.2013.09.008
  • Allen AM, Jung AM, Alexander AC, et al. Cannabis use and stressful life events during the perinatal period: cross‐sectional results from Pregnancy Risk Assessment Monitoring System (PRAMS) Data, 2016. Addiction. 2020;115(9):1707–1716. doi:10.1111/add.15003
  • Pike CK, Sofis MJ, Budney AJ. Correlates of continued cannabis use during pregnancy. Drug Alcohol Depend. 2021;227:108939. doi:10.1016/j.drugalcdep.2021.108939
  • de Salut D. Protocol de seguiment de l’embaràs a Catalunya. Barcelona: Generalitat de Catalunya. Departament de Salut. Agència de Salut Pública de Catalunya; 2005.
  • Graves LE, Robert M, Allen VM, et al. Guideline no. 425b: cannabis use throughout women’s lifespans – part 2: pregnancy, the postnatal period, and breastfeeding. J Obstet Gynaecol Can. 2022;44(4):436–444.e1. doi:10.1016/j.jogc.2022.01.013
  • Asociacion Española de Pediatria; 2019. Available from: https://www.aeped.es/sites/default/files/documentos/cannabis_durante_el_embarazo_y_lactanciaaep6.pdf
  • Agencia Tributaria- Gobierno de España. Estadística declarantes del IRPF mayores municipios por código postal; 2019. Available from: https://sede.agenciatributaria.gob.es/Sede/datosabiertos/catalogo/hacienda/Estadistica_del_IRPF_por_codigo_postal.shtml.
  • Web PEDiatrica; 2023. Available from: http://www.webpediatrica.com/endocrinoped/antropometria.php.
  • Manthey J, Freeman TP, Kilian C, et al. Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. Lancet Reg Health Eur. 2021;10:100227. doi:10.1016/j.lanepe.2021.100227
  • Blasco-Alonso M, González-Mesa E, Gálvez Montes M, et al. Exposure to tobacco, alcohol and drugs of abuse during pregnancy. A study of prevalence among pregnant women in Malaga (Spain). Adicciones. 2015;27(2):99–108. doi:10.20882/adicciones.695
  • Protocol d’actuació davant de maltractaments en la infància i l’adolescència en l’àmbit de la salut. Barcelona: Generalitat de Catalunya. Departament de Salut; 2019.
  • Singh S, Filion KB, Abenhaim HA, et al. Prevalence and outcomes of prenatal recreational cannabis use in high-income countries: a scoping review. BJOG. 127(1):8–16. doi:10.1111/1471-0528.15946
  • Ruisch IH, Dietrich A, Glennon JC, et al. Maternal substance use during pregnancy and offspring conduct problems: a meta-analysis. Neurosci Biobehav Rev. 2018;84:325–336. doi:10.1016/j.neubiorev.2017.08.014
  • Ko JY, Coy KC, Haight SC, et al. Characteristics of marijuana use during pregnancy—eight states, pregnancy risk assessment monitoring system, 2017. MMWR Morb Mortal Wkly Rep. 2020;69(32):1058–1063. doi:10.15585/mmwr.mm6932a2
  • McDonnell BP, Keogan S, Clancy L, et al. Smoking cessation support and obstetric outcomes in an Irish Maternity Hospital. Eur J Obstet Gynecol Reprod Biol. 2019;232:1–4. doi:10.1016/j.ejogrb.2018.11.005
  • Chang JC, Tarr JA, Holland CL, et al. Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use. Drug Alcohol Depend. 2019;196:14–20. doi:10.1016/j.drugalcdep.2018.11.028
  • Dickson B, Mansfield C, Guiahi M, et al. Recommendations from cannabis dispensaries about first-trimester cannabis use. Obstet Gynecol. 2018;131(6):1031–1038. doi:10.1097/AOG.0000000000002619
  • Rubio Valladolid G, Martinez Raga J, Martinez-Gras I, et al. Validation of the Spanish version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Psicothema. 2014;26(2):180–185.
  • Lozano J, García-Algar O, Vall O, et al. Biological matrices for the evaluation of in utero exposure to drugs of abuse. Ther Drug Monit. 2007;29(6):711–734.
  • Terplan M. Commentary on Ondersma et al. (2012): beyond the quest for the perfect test-drug use screening in pregnancy. Addiction. 2012;107(12):2107–2108. doi:10.1111/j.1360-0443.2012.04094.x
  • Wernette GT, Plegue M, Kahler CW, et al. A pilot randomized controlled trial of a computer-delivered brief intervention for substance use and risky sex during pregnancy. J Womens Health. 2018;27(1):83–92. doi:10.1089/jwh.2017.6408
  • Foti TR, Green A, Altschuler A, et al. Patient perceptions of prenatal cannabis use and implications for clinicians. Obstet Gynecol. 2023;142(5):1153–1161. doi:10.1097/AOG.0000000000005295
  • Daniels S, St. Pierre M, Sanchez T, et al. Physician communication and perceived stigma in prenatal cannabis use. J Psychoact Drugs. 2023;55(3):290–298. doi:10.1080/02791072.2022.2076179
  • Regalado D, Connolly ME, Krutsch K, et al. Psychiatric medication use among pregnant and breastfeeding mothers who used cannabis for mental health concerns: a cross-sectional survey study. Women’s Health. 2023;19:17455057231199391.
  • Gunn JKL, Rosales CB, Center KE, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986. doi:10.1136/bmjopen-2015-009986
  • Baía I, Domingues RMSM. The effects of cannabis use during pregnancy on low birth weight and preterm birth: a systematic review and meta-analysis. Am J Perinatol. 2024;41(1):17–30. doi:10.1055/a-1911-3326
  • Joseph-Lemon L, Thompson H, Verostick L, et al. Outcomes of cannabis use during pregnancy within the American Association of Birth Centers Perinatal Data Registry 2007–2020. J Perinat Neonatal Nurs. 2022;36(3):264–273. doi:10.1097/JPN.0000000000000668